Cover Image
市場調查報告書

水凝膠:開發平台分析

Hydrogels - Pipeline Review, 2015

出版商 GlobalData 商品編碼 341585
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
水凝膠:開發平台分析 Hydrogels - Pipeline Review, 2015
出版日期: 2015年09月04日 內容資訊: 英文 109 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的水凝膠之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 水凝膠概要

第3章 開發中的產品

  • 水凝膠 - 各開發階段的開發中產品
  • 水凝膠 - 各市場區隔的開發中產品
  • 水凝膠 -國家 (地區) 別的開發中產品
  • 水凝膠 - 法規別的開發中產品
  • 水凝膠 - 核准時期 (估計) 別的開發中產品
  • 水凝膠 - 現在進行中的臨床實驗

第4章 水凝膠 - 正在開發的開發中產品:各企業

  • 水凝膠企業 - 各開發階段的開發中產品
  • 水凝膠 - 各開發階段的開發中產品

第5章 水凝膠企業與產品概要

  • 3QMatrix, Inc.
  • Abeona Therapeutics, Inc.
  • Alafair Biosciences, Inc.
  • Asana Medical, Inc.
  • BioCure, Inc.
  • Biomendics, LLC
  • BioTime, Inc.
  • Brigham and Women's Hospital
  • CelaCare Technologies, Inc.
  • Chi2Gel Ltd.
  • Consejo Superior de Investigaciones Cientificas
  • Corium International, Inc.
  • Edixomed Ltd
  • FzioMed, Inc.
  • Halscion, Inc.
  • HyperBranch Medical Technology, Inc.
  • InVivo Therapeutics Corporation
  • IPI Singapore
  • KeraNetics, LLC
  • Maxigen Biotech Inc.
  • Medtric Biotech, LLC
  • Newcastle University
  • Northwestern University
  • Oculus Innovative Sciences, Inc.
  • Oxtex Limited
  • Pharmagenix AG
  • Piramal Enterprises Limited
  • Plurogen Therapeutics, Inc.
  • Quick-Med Technologies, Inc.
  • Surgical Specialties Corporation (Inactive)
  • Tel Aviv University
  • The Johns Hopkins University
  • The University of Queensland
  • University of Akron
  • University of California, San Diego
  • Ventrix, Inc.
  • Zeomedix, LLC

第6章 水凝膠 - 最近的趨勢

第7章 附錄

目錄
Product Code: GDME0061EPD

GlobalData's Medical Devices sector report, "Hydrogels - Pipeline Review, 2015" provides an overview of Hydrogels currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hydrogels pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hydrogels under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hydrogels under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Hydrogels Overview

3. Products under Development

  • 3.1. Hydrogels - Pipeline Products by Stage of Development
  • 3.2. Hydrogels - Pipeline Products by Segment
  • 3.3. Hydrogels - Pipeline Products by Territory
  • 3.4. Hydrogels - Pipeline Products by Regulatory Path
  • 3.5. Hydrogels - Pipeline Products by Estimated Approval Date
  • 3.6. Hydrogels - Ongoing Clinical Trials

4. Hydrogels - Pipeline Products under Development by Companies

  • 4.1. Hydrogels Companies - Pipeline Products by Stage of Development
  • 4.2. Hydrogels - Pipeline Products by Stage of Development

5. Hydrogels Companies and Product Overview

  • 5.1. 3QMatrix, Inc. Company Overview
    • 5.1.1. 3QMatrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Abeona Therapeutics, Inc. Company Overview
    • 5.2.1. Abeona Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Alafair Biosciences, Inc. Company Overview
    • 5.3.1. Alafair Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Asana Medical, Inc. Company Overview
    • 5.4.1. Asana Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. BioCure, Inc. Company Overview
    • 5.5.1. BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Biomendics, LLC Company Overview
    • 5.6.1. Biomendics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BioTime, Inc. Company Overview
    • 5.7.1. BioTime, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Brigham and Women's Hospital Company Overview
    • 5.8.1. Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. CelaCare Technologies, Inc. Company Overview
    • 5.9.1. CelaCare Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Chi2Gel Ltd. Company Overview
    • 5.10.1. Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Consejo Superior de Investigaciones Cientificas Company Overview
    • 5.11.1. Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Corium International, Inc. Company Overview
    • 5.12.1. Corium International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Edixomed Ltd Company Overview
    • 5.13.1. Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. FzioMed, Inc. Company Overview
    • 5.14.1. FzioMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Halscion, Inc. Company Overview
    • 5.15.1. Halscion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. HyperBranch Medical Technology, Inc. Company Overview
    • 5.16.1. HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. InVivo Therapeutics Corporation Company Overview
    • 5.17.1. InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. IPI Singapore Company Overview
    • 5.18.1. IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. KeraNetics, LLC Company Overview
    • 5.19.1. KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Maxigen Biotech Inc. Company Overview
    • 5.20.1. Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Medtric Biotech, LLC Company Overview
    • 5.21.1. Medtric Biotech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Newcastle University Company Overview
    • 5.22.1. Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Northwestern University Company Overview
    • 5.23.1. Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Oculus Innovative Sciences, Inc. Company Overview
    • 5.24.1. Oculus Innovative Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Oxtex Limited Company Overview
    • 5.25.1. Oxtex Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Pharmagenix AG Company Overview
    • 5.26.1. Pharmagenix AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Piramal Enterprises Limited Company Overview
    • 5.27.1. Piramal Enterprises Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Plurogen Therapeutics, Inc. Company Overview
    • 5.28.1. Plurogen Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Quick-Med Technologies, Inc. Company Overview
    • 5.29.1. Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Surgical Specialties Corporation (Inactive) Company Overview
    • 5.30.1. Surgical Specialties Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Tel Aviv University Company Overview
    • 5.31.1. Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. The Johns Hopkins University Company Overview
    • 5.32.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. The University of Queensland Company Overview
    • 5.33.1. The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. University of Akron Company Overview
    • 5.34.1. University of Akron Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. University of California, San Diego Company Overview
    • 5.35.1. University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Ventrix, Inc. Company Overview
    • 5.36.1. Ventrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Zeomedix, LLC Company Overview
    • 5.37.1. Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview

6. Hydrogels- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Hydrogels - Pipeline Products by Stage of Development
  • Table 2: Hydrogels - Pipeline Products by Segment
  • Table 3: Hydrogels - Pipeline Products by Territory
  • Table 4: Hydrogels - Pipeline Products by Regulatory Path
  • Table 5: Hydrogels - Pipeline Products by Estimated Approval Date
  • Table 6: Hydrogels - Ongoing Clinical Trials
  • Table 7: Hydrogels Companies - Pipeline Products by Stage of Development
  • Table 8: Hydrogels - Pipeline Products by Stage of Development
  • Table 9: 3QMatrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Bi-layer Dressing - Product Status
  • Table 11: Bi-layer Dressing - Product Description
  • Table 12: Abeona Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: BenzaGard - Product Status
  • Table 14: BenzaGard - Product Description
  • Table 15: Alafair Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Alafair Bilayer - Product Status
  • Table 17: Alafair Bilayer - Product Description
  • Table 18: Alafair Film - Product Status
  • Table 19: Alafair Film - Product Description
  • Table 20: Alafair Injectable Gel - Product Status
  • Table 21: Alafair Injectable Gel - Product Description
  • Table 22: Alafair Membrane - Product Status
  • Table 23: Alafair Membrane - Product Description
  • Table 24: Asana Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: ExtraCellular Matrix Hydrogel - Product Status
  • Table 26: ExtraCellular Matrix Hydrogel - Product Description
  • Table 27: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: BCNP - Product Status
  • Table 29: BCNP - Product Description
  • Table 30: Growth Factor Delivery - Hydrogel Wound Dressing - Product Status
  • Table 31: Growth Factor Delivery - Hydrogel Wound Dressing - Product Description
  • Table 32: Spray-On dressings - Product Status
  • Table 33: Spray-On dressings - Product Description
  • Table 34: Biomendics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Wound Gel - Product Status
  • Table 36: Wound Gel - Product Description
  • Table 37: BioTime, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: ReGlyde - Product Status
  • Table 39: ReGlyde - Product Description
  • Table 40: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: ELP Hydrogel - Product Status
  • Table 42: ELP Hydrogel - Product Description
  • Table 43: CelaCare Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: OTC Antimicrobial Gel - Product Status
  • Table 45: OTC Antimicrobial Gel - Product Description
  • Table 46: Prescription Gel 1 - Product Status
  • Table 47: Prescription Gel 1 - Product Description
  • Table 48: Prescription Gel 2 - Product Status
  • Table 49: Prescription Gel 2 - Product Description
  • Table 50: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Chi2Gel Wound Dressing - Product Status
  • Table 52: Chi2Gel Wound Dressing - Product Description
  • Table 53: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Multicomponent Hydrogel - Product Status
  • Table 55: Multicomponent Hydrogel - Product Description
  • Table 56: Corium International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Hydrogel Dressing - Product Status
  • Table 58: Hydrogel Dressing - Product Description
  • Table 59: Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: NOx Dressing - Burns - Product Status
  • Table 61: NOx Dressing - Burns - Product Description
  • Table 62: NOx Dressing - Diabetic Foot Ulcer - Product Status
  • Table 63: NOx Dressing - Diabetic Foot Ulcer - Product Description
  • Table 64: NOx Dressing - Pressure Ulcers - Product Status
  • Table 65: NOx Dressing - Pressure Ulcers - Product Description
  • Table 66: NOx Dressing - Surgical Wounds - Product Status
  • Table 67: NOx Dressing - Surgical Wounds - Product Description
  • Table 68: NOx Dressing - Venous Leg Ulcers - Product Status
  • Table 69: NOx Dressing - Venous Leg Ulcers - Product Description
  • Table 70: Edixomed Ltd - Ongoing Clinical Trials Overview
  • Table 71: NOx Dressing - Diabetic Foot Ulcer - A Clinical Pilot Study of an Oxides of Nitrogen Generating Gel Dressing System to Stimulate Healing in Diabetic Foot Ulcers
  • Table 72: NOx Dressing - Burns - A Clinical Study of Superficial Partial Thickness Wound Treatment with an Oxides of Nitrogen Generating Gel Dressing - ProNOx 2
  • Table 73: FzioMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Oxiplex/SP Gel - Product Status
  • Table 75: Oxiplex/SP Gel - Product Description
  • Table 76: FzioMed, Inc. - Ongoing Clinical Trials Overview
  • Table 77: Oxiplex/SP Gel - A Bioresorbable Product Designed To Reduce Adhesions From Lumbar Surgery: A Clinical Study
  • Table 78: Halscion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Celotres - Product Status
  • Table 80: Celotres - Product Description
  • Table 81: Halscion, Inc. - Ongoing Clinical Trials Overview
  • Table 82: Celotres - A Post Market Clinical Study Evaluating the Safety, Device Performance and Possible Emergent Risks of Celotres in the Improvement of Wound Healing and the Resulting Scar Consequences Following Suturing of a Wound
  • Table 83: HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Adherus MIS - Product Status
  • Table 85: Adherus MIS - Product Description
  • Table 86: InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Injectable Hydrogel - Fibrosis - Product Status
  • Table 88: Injectable Hydrogel - Fibrosis - Product Description
  • Table 89: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Hyaluronic Acid-Based Gel - Product Status
  • Table 91: Hyaluronic Acid-Based Gel - Product Description
  • Table 92: Keratin Hydrogel - Product Status
  • Table 93: Keratin Hydrogel - Product Description
  • Table 94: KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: KeraStat Burn Gel - Product Status
  • Table 96: KeraStat Burn Gel - Product Description
  • Table 97: Keratin-Based Hydrogel Wound Dressing - Product Status
  • Table 98: Keratin-Based Hydrogel Wound Dressing - Product Description
  • Table 99: Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: MaxiGel - Product Status
  • Table 101: MaxiGel - Product Description
  • Table 102: Medtric Biotech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Osmotec - Traditional Gel - Product Status
  • Table 104: Osmotec - Traditional Gel - Product Description
  • Table 105: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: Synthetic ECM Hydrogel - Product Status
  • Table 107: Synthetic ECM Hydrogel - Product Description
  • Table 108: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Biocompatible Hydrogel - Product Status
  • Table 110: Biocompatible Hydrogel - Product Description
  • Table 111: pH Responsive Self-Healing Hydrogel - Product Status
  • Table 112: pH Responsive Self-Healing Hydrogel - Product Description
  • Table 113: Tissue Sealant - Fetal Membrane Repair - Product Status
  • Table 114: Tissue Sealant - Fetal Membrane Repair - Product Description
  • Table 115: Oculus Innovative Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Dermacyn SkinGuard Hydrogel - Product Status
  • Table 117: Dermacyn SkinGuard Hydrogel - Product Description
  • Table 118: Dermacyn Wound Care Hydrogel - Product Status
  • Table 119: Dermacyn Wound Care Hydrogel - Product Description
  • Table 120: Oxtex Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Oxtex Tissue Expander - Product Status
  • Table 122: Oxtex Tissue Expander - Product Description
  • Table 123: Pharmagenix AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: PGX-10 - Product Status
  • Table 125: PGX-10 - Product Description
  • Table 126: Piramal Enterprises Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: BST-DermOn - Product Status
  • Table 128: BST-DermOn - Product Description
  • Table 129: Plurogen Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 130: PluroGel PNN - Product Status
  • Table 131: PluroGel PNN - Product Description
  • Table 132: Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 133: Nimbus Hydrogel - Product Status
  • Table 134: Nimbus Hydrogel - Product Description
  • Table 135: Surgical Specialties Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 136: Adhibit - Product Status
  • Table 137: Adhibit - Product Description
  • Table 138: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 139: Self Assembled Peptide Hydrogel (SAPH) - Product Status
  • Table 140: Self Assembled Peptide Hydrogel (SAPH) - Product Description
  • Table 141: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 142: Chondroitin Sulfate Hydrogel - Product Status
  • Table 143: Chondroitin Sulfate Hydrogel - Product Description
  • Table 144: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 145: Peptide Hydrogel - Product Status
  • Table 146: Peptide Hydrogel - Product Description
  • Table 147: University of Akron Pipeline Products & Ongoing Clinical Trials Overview
  • Table 148: OXAID Hydrogel Wound Dressing - Product Status
  • Table 149: OXAID Hydrogel Wound Dressing - Product Description
  • Table 150: University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Table 151: Self Healing Hydrogel - Product Status
  • Table 152: Self Healing Hydrogel - Product Description
  • Table 153: Ventrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 154: VentriGel - Product Status
  • Table 155: VentriGel - Product Description
  • Table 156: Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 157: Zeomedix Hydrogel - Product Status
  • Table 158: Zeomedix Hydrogel - Product Description
  • Table 159: Glossary

List of Figures

  • Figure 1: Hydrogels - Pipeline Products by Stage of Development
  • Figure 2: Hydrogels - Pipeline Products by Segment
  • Figure 3: Hydrogels - Pipeline Products by Territory
  • Figure 4: Hydrogels - Pipeline Products by Regulatory Path
  • Figure 5: Hydrogels - Pipeline Products by Estimated Approval Date
  • Figure 6: Hydrogels - Ongoing Clinical Trials
Back to Top